Revvity Cash Flow from Operating Activities 2010-2025 | RVTY

Revvity annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.
  • Revvity cash flow from operating activities for the quarter ending March 31, 2025 was $0.128B, a 13.15% decline year-over-year.
  • Revvity cash flow from operating activities for the twelve months ending March 31, 2025 was $1.517B, a 2360.67% increase year-over-year.
  • Revvity annual cash flow from operating activities for 2024 was $0.628B, a 588.38% increase from 2023.
  • Revvity annual cash flow from operating activities for 2023 was $0.091B, a 86.57% decline from 2022.
  • Revvity annual cash flow from operating activities for 2022 was $0.68B, a 51.81% decline from 2021.
Revvity Annual Cash Flow Ops
(Millions of US $)
2024 $628
2023 $91
2022 $680
2021 $1,411
2020 $892
2019 $363
2018 $311
2017 $288
2016 $351
2015 $287
2014 $282
2013 $159
2012 $152
2011 $225
2010 $164
2009 $149
Sector Industry Market Cap Revenue
Medical Medical Services $10.729B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $134.417B 25.21
Elevance Health (ELV) United States $84.565B 10.91
CVS Health (CVS) United States $75.952B 9.44
Cencora (COR) United States $54.132B 18.82
DiDi Global (DIDIY) China $21.231B 32.22
Natera (NTRA) United States $20.665B 0.00
BioMerieux (BMXMF) France $15.263B 0.00
Solventum (SOLV) United States $12.308B 13.03
EUROFINS SCIENT (ERFSF) Luxembourg $12.132B 0.00
Doximity (DOCS) United States $11.108B 57.77
CochLear (CHEOY) Australia $11.097B 0.00
ICON (ICLR) Ireland $10.678B 9.93
Viatris (VTRS) United States $9.882B 3.40
Avantor (AVTR) United States $8.756B 12.72
HealthEquity (HQY) United States $8.482B 41.73
Medpace Holdings (MEDP) United States $8.385B 22.27
Sonic Healthcare (SKHHY) Australia $8.090B 0.00
Charles River Laboratories (CRL) United States $6.825B 13.37
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.093B 37.89
Bausch + Lomb (BLCO) Canada $4.082B 24.06
Sotera Health (SHC) United States $3.636B 20.66
Alignment Healthcare (ALHC) United States $2.950B 0.00
Surgery Partners (SGRY) United States $2.918B 37.95
Concentras Parent (CON) United States $2.739B 15.83
Organon (OGN) United States $2.090B 2.22
Ardent Health Partners (ARDT) United States $2.084B 8.88
Premier (PINC) United States $2.056B 14.07
Progyny (PGNY) United States $1.874B 41.24
GeneDx Holdings (WGS) United States $1.696B 65.33
PACS (PACS) United States $1.666B 0.00
GoodRx Holdings (GDRX) United States $1.638B 30.50
Teladoc Health (TDOC) United States $1.288B 0.00
Pediatrix Medical (MD) United States $1.219B 9.27
Agilon Health (AGL) United States $1.105B 0.00
Establishment Labs Holdings (ESTA) $1.054B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.892B 13.93
Nutex Health (NUTX) United States $0.884B 13.36
AMN Healthcare Services Inc (AMN) United States $0.833B 7.80
QDM (QDMI) Hong Kong, SAR China $0.691B 0.00
Embecta (EMBC) United States $0.677B 4.56
InnovAge Holding (INNV) United States $0.554B 0.00
Enhabit (EHAB) United States $0.536B 44.08
Auna S.A (AUNA) Luxembourg $0.514B 13.61
Sonida Senior Living (SNDA) United States $0.496B 0.00
LifeMD (LFMD) United States $0.434B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.358B 0.00
SBC Medicals (SBC) United States $0.348B 0.00
Performant Healthcare (PHLT) United States $0.203B 0.00
Beauty Health (SKIN) United States $0.185B 0.00
Oncology Institute (TOI) United States $0.179B 0.00
DocGo (DCGO) United States $0.143B 23.33
So-Young (SY) China $0.086B 0.00
Sera Prognostics (SERA) United States $0.085B 0.00
OncoCyte (OCX) United States $0.074B 0.00
Ascend Wellness Holdings (AAWH) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
KindlyMD (KDLY) United States $0.046B 0.00
Basel Medical Group (BMGL) Singapore $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
Pheton Holdings (PTHL) China $0.033B 0.00
Biodesix (BDSX) United States $0.032B 0.00
ModivCare (MODV) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00